YahooOctober 21, 2026 at 11:04 AM NY6 Days Ago
Danaher Q3 Earnings Call Highlights
Danaher (NYSE:DHR) reported third-quarter 2026 results that exceeded its expectations, citing improved market conditions, commercial execution and operational performance across its Biotechnology, Life Sciences and Diagnostics businesses. Sales totaled $6.6 billion for the quarter. Core revenue gro
What This Story Means
Claude is explaining the story in plain words…
Read the Full Story at the Source
The summary here comes from the news provider; the rest of the article lives on the publisher's site: Yahoo
